These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 13240148)

  • 1. Effect of 9 alpha-fluorohydrocortisone on adrenal hyperfunction in Cushing's syndrome.
    COPE CL; HARRISON RJ
    Br Med J; 1955 Aug; 2(4937):457-60. PubMed ID: 13240148
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of corticotropin and 9alpha-fluorohydrocortisone on urinary steroids in Cushing's syndrome.
    JENKINS JS; SPENCE AW
    J Clin Endocrinol Metab; 1957 May; 17(5):621-31. PubMed ID: 13416372
    [No Abstract]   [Full Text] [Related]  

  • 3. CONCENTRATION OF CORTICOSTERONE AND HYDROCORTISONE IN THE PLASMA OF PATIENTS WITH CUSHING'S SYNDROME CAUSED BY HYPERPLASIA OR TUMOUR OF THE ADRENAL CORTEX.
    BRORSON I
    Acta Chir Scand; 1964; 127():162-71. PubMed ID: 14104698
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary 6 beta-hydroxy-cortisol in adrenocortical hyperfunction.
    TOUCHSTONE JC; BLAKEMORE WS
    J Clin Endocrinol Metab; 1961 Mar; 21():263-70. PubMed ID: 13777691
    [No Abstract]   [Full Text] [Related]  

  • 5. AN ALTERATION IN CORTISOL METABOLISM IN PATIENTS WITH CUSHING'S SYNDROME AND BILATERAL ADRENAL HYPERPLASIA.
    GUIGNARD-DEMAEYER JA; CRIGLER JF; GOLD NI
    J Clin Endocrinol Metab; 1963 Dec; 23():1271-84. PubMed ID: 14087608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Failure of the intravenous ACTH tests in a case of Cushing's syndrome following bilateral hyperplasia of the adrenal cortex. Postoperative substitution of a 21-desoxysteroid].
    TAMM J; VOIGT KD; KRACHT J
    Acta Endocrinol (Copenh); 1961 Jun; 37():253-62. PubMed ID: 13775113
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the adrenal hyperfunction in 2 patients with atypical Cushing's syndrome.
    MELLINGER RC; SMITH RW
    J Clin Endocrinol Metab; 1956 Mar; 16(3):350-66. PubMed ID: 13295366
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in Cushing's syndrome. III. Urinary 17-ketosteroids in patients with bilateral adrenal cortical hyperplasia.
    JAILER JW; VANDE WIELE R; CHRISTY NP; LIEBERMAN S
    J Clin Invest; 1959 Feb; 38(2):357-65. PubMed ID: 13631067
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary formaldehydrogenic corticoid as determined after enzymatic hydrolysis in normal subjects and in patients with adrenal and hypertensive disease.
    DUSTAN HP; MASON HL; CORCORAN AC
    J Clin Invest; 1953 Jan; 32(1):60-7. PubMed ID: 13011209
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the urinary excretion of alpha-ketolic corticoids and aldosterone during Cushing's syndrome].
    ROMANI JD; ALBEAUX-FERNET M; CHABOT J
    Rev Med Fr; 1961 Jan; 42():15-6. PubMed ID: 24545746
    [No Abstract]   [Full Text] [Related]  

  • 11. URINARY CORTICOSTEROID EXCRETION IN OBESE ADULTS.
    BAIRD IM
    Lancet; 1963 Nov; 2(7316):1022-6. PubMed ID: 14062719
    [No Abstract]   [Full Text] [Related]  

  • 12. [ADRENAL CORTEX FUNCTION. DETERMINATION OF THE URINARY AND PLASMATIC 17,21-DIHYDROXY-20-KETOSTEROIDS IN THE DIAGNOSIS OF CUSHING'S SYNDROME].
    WAJCHENBERG BL
    Arq Bras Endocrinol Metabol; 1963 Dec; 12():153-76. PubMed ID: 14164197
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of L-triodothyronine on steroid hormone metabolism: studies in a patient with adrenal hyperplasia (Cushing's syndrome).
    GOLD NI; CRIGLER JF
    J Clin Endocrinol Metab; 1963 Feb; 23():156-66. PubMed ID: 13948647
    [No Abstract]   [Full Text] [Related]  

  • 14. CUSHING'S SYNDROME: NODULAR CORTICAL HYPERPLASIA OF ADRENAL GLANDS WITH CLINICAL AND PATHOLOGICAL FEATURES SUGGESTING ADRENOCORTICAL TUMOR.
    KIRSCHNER MA; POWELL RD; LIPSETT MB
    J Clin Endocrinol Metab; 1964 Oct; 24():947-55. PubMed ID: 14228534
    [No Abstract]   [Full Text] [Related]  

  • 15. [ENDOCRINOLOGICAL OBSERVATIONS ON CUSHING'S SYNDROME].
    KOSEKI A; SHINOHARA M; MURAYAMA K; TAKANO J; TSUNOKAKE H; MITSUBE K
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Dec; 15():1365-71. PubMed ID: 14100054
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary-adrenal hyperfunction.
    SIMPSON SL
    Proc R Soc Med; 1953 Jan; 46(1):39-44. PubMed ID: 13027290
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary 17-keto-steroid and 17-ketogenic steroid excretion in Cushing's syndrome.
    HEIDER CH; HANDLEY CA; FORD RV
    J Clin Endocrinol Metab; 1959 Nov; 19():1471-6. PubMed ID: 14400611
    [No Abstract]   [Full Text] [Related]  

  • 18. [SIGNIFICANCE OF THE EVALUATION OF URINARY PREGNANTRIOL IN SOME ADRENAL ENDOCRINE DISORDERS: FINDINGS IN BASAL CONDITIONS AND AFTER TREATMENTS STIMULATING OR INHIBITING THE ADRENAL CORTEX].
    FAGLIA G; D ALONZO R; NORBIATO G; ORTHMANN G; LIUZZI A
    Arch Patol Clin Med; 1964 Jan; 40():278-315. PubMed ID: 14124741
    [No Abstract]   [Full Text] [Related]  

  • 19. [PLASMATIC ESTROGENS IN BILATERAL HYPERPLASIA OF THE ADRENAL CORTEX. COMPARATIVE STUDY IN CONGENITAL ADRENOGENITAL SYNDROME AND CUSHING'S SYNDROME].
    SCIARRA F; SORCINI G; CONCOLINO G; RASCIO L
    Folia Endocrinol; 1964 Oct; 17():556-67. PubMed ID: 14265045
    [No Abstract]   [Full Text] [Related]  

  • 20. ADRENAL CORTICAL HYPERFUNCTION ASSOCIATED WITH BRONCHOGENIC CARCINOMA.
    MCDANIEL HG; PITTMAN JA; HILL SR; STARNES WR
    Am J Med; 1963 Sep; 35():427-33. PubMed ID: 14065884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.